Artificial intelligence for the detection of COVID-19 pneumonia on chest CT using multinational datasets

Chest CT is emerging as a valuable diagnostic tool for clinical management of COVID-19 associated lung disease. Artificial intelligence (AI) has the potential to aid in rapid evaluation of CT scans for differentiation of COVID-19 findings from other clinical entities. Here we show that a series of d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature communications 2020-08, Vol.11 (1), p.4080-7, Article 4080
Hauptverfasser: Harmon, Stephanie A., Sanford, Thomas H., Xu, Sheng, Turkbey, Evrim B., Roth, Holger, Xu, Ziyue, Yang, Dong, Myronenko, Andriy, Anderson, Victoria, Amalou, Amel, Blain, Maxime, Kassin, Michael, Long, Dilara, Varble, Nicole, Walker, Stephanie M., Bagci, Ulas, Ierardi, Anna Maria, Stellato, Elvira, Plensich, Guido Giovanni, Franceschelli, Giuseppe, Girlando, Cristiano, Irmici, Giovanni, Labella, Dominic, Hammoud, Dima, Malayeri, Ashkan, Jones, Elizabeth, Summers, Ronald M., Choyke, Peter L., Xu, Daguang, Flores, Mona, Tamura, Kaku, Obinata, Hirofumi, Mori, Hitoshi, Patella, Francesca, Cariati, Maurizio, Carrafiello, Gianpaolo, An, Peng, Wood, Bradford J., Turkbey, Baris
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Chest CT is emerging as a valuable diagnostic tool for clinical management of COVID-19 associated lung disease. Artificial intelligence (AI) has the potential to aid in rapid evaluation of CT scans for differentiation of COVID-19 findings from other clinical entities. Here we show that a series of deep learning algorithms, trained in a diverse multinational cohort of 1280 patients to localize parietal pleura/lung parenchyma followed by classification of COVID-19 pneumonia, can achieve up to 90.8% accuracy, with 84% sensitivity and 93% specificity, as evaluated in an independent test set (not included in training and validation) of 1337 patients. Normal controls included chest CTs from oncology, emergency, and pneumonia-related indications. The false positive rate in 140 patients with laboratory confirmed other (non COVID-19) pneumonias was 10%. AI-based algorithms can readily identify CT scans with COVID-19 associated pneumonia, as well as distinguish non-COVID related pneumonias with high specificity in diverse patient populations. Chest CT is emerging as a valuable diagnostic tool for clinical management of COVID-19 associated lung disease. Here, the authors present a multinational study on the application of deep learning algorithms for COVID-19 diagnosis against multiple lung conditions as controls.
ISSN:2041-1723
2041-1723
DOI:10.1038/s41467-020-17971-2